Bicycle Therapeutics (BCYC) Other Accumulated Expenses (2018 - 2026)

Bicycle Therapeutics' Other Accumulated Expenses history runs 9 years deep, the most recent figure standing at $483000.0 for Q1 2026.

• Quarterly Other Accumulated Expenses rose 56.31% year-over-year to $483000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $483000.0 (up 56.31% YoY) and the FY2025 annual result came in at $136000.0, down 54.21% from the prior year.
• Other Accumulated Expenses was $483000.0 for Q1 2026 at Bicycle Therapeutics, up from $136000.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $1.5 million in Q4 2022 and bottomed at $136000.0 in Q4 2025.
• A 5-year average of $504529.4 and a median of $384000.0 in 2022 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2022 — Other Accumulated Expenses soared 1396.88% — and 2023, when it sank 82.54%.
• Bicycle Therapeutics' Other Accumulated Expenses stood at $1.5 million in 2022, then plunged by 82.54% to $257000.0 in 2023, then advanced by 15.56% to $297000.0 in 2024, then tumbled by 54.21% to $136000.0 in 2025, then jumped by 255.15% to $483000.0 in 2026.
• Business Quant data shows BCYC's Other Accumulated Expenses at $483000.0 in Q1 2026, $136000.0 in Q4 2025, and $204000.0 in Q3 2025.